|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| C07K 14/605 | (2013.01) | ||
| C07K 14/605 | (2006.01) | ||
| C07K 14/57563 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07K 14/575 | (2006.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 4000630 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21194436.8 |
| Date of filing the European patent application | 2015-08-25 | |
| (97) | Date of publication of the European application | 2022-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201415598 | 2014-09-03 | GB |
| (72) |
SINCLAIR, Alex , GB
|
| (73) |
Invex Therapeutics Ltd ,
Level 1
38 Rowland St., Subiaco, Perth WA 6008,
AU
|
| (54) | INCRETIN FOR ELEVATED INTRACRANIAL PRESSURE TREATMENT |
| INCRETIN FOR ELEVATED INTRACRANIAL PRESSURE TREATMENT |